MENU
+Compare
ORGO
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$3.07
Change
-$0.10 (-3.15%)
Capitalization
374.78M

ORGO Organogenesis Holdings Forecast, Technical & Fundamental Analysis

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets... Show more

ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ORGO with price predictions
Jun 13, 2025

ORGO's RSI Indicator ascending out of oversold territory

The RSI Indicator for ORGO moved out of oversold territory on June 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 06, 2025. You may want to consider a long position or call options on ORGO as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORGO just turned positive on June 05, 2025. Looking at past instances where ORGO's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ORGO advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where ORGO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

ORGO moved below its 50-day moving average on May 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ORGO crossed bearishly below the 50-day moving average on May 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORGO broke above its upper Bollinger Band on June 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ORGO entered a downward trend on June 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ORGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.331) is normal, around the industry mean (62.115). P/E Ratio (70.250) is within average values for comparable stocks, (88.968). ORGO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (0.861) is also within normal values, averaging (19.096).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ORGO is expected to report earnings to fall 63.24% to -6 cents per share on August 06

Organogenesis Holdings ORGO Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Missed
by $0.13
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.11
Q2'24
Missed
by $0.14
The last earnings report on May 08 showed earnings per share of -17 cents, missing the estimate of -3 cents. With 494.81K shares outstanding, the current market capitalization sits at 374.78M.
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
85 Dan Road
Phone
+1 781 575-0775
Employees
862
Web
https://www.organogenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MYINX8.90-0.08
-0.89%
NYLI WMC International Rsrch Eq Inv Cl
LAVPX14.88-0.14
-0.93%
Lord Abbett Fundamental Equity P
FLUEX26.16-0.27
-1.02%
Fidelity Advisor Stk Selec Lg Cp Val C
TGADX28.81-0.39
-1.34%
Templeton Growth Adv
TSMDX14.97-0.23
-1.51%
Trillium ESG Small/Mid Cap Institutional

ORGO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-3.15%
ANIP - ORGO
48%
Loosely correlated
+0.71%
PRGO - ORGO
46%
Loosely correlated
-2.20%
AMRX - ORGO
31%
Poorly correlated
-2.64%
GTBIF - ORGO
29%
Poorly correlated
-1.16%
CURLF - ORGO
29%
Poorly correlated
-4.17%
More